Quest for controls in molecular genetics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Cystic fibrosis testing comes of age.The Journal of molecular diagnostics : JMD · 2009
   Article
2. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).BMC medical genetics · 2006
   Article
3. A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.The Journal of molecular diagnostics : JMD · 2005
   Article
4. Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms.The Journal of molecular diagnostics : JMD · 2004
   Article

Corrections and comments

• Comment on
  Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.2003

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as